1. Home
  2. STAA vs XIFR Comparison

STAA vs XIFR Comparison

Compare STAA & XIFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STAA
  • XIFR
  • Stock Information
  • Founded
  • STAA 1982
  • XIFR 2014
  • Country
  • STAA United States
  • XIFR United States
  • Employees
  • STAA 1211
  • XIFR N/A
  • Industry
  • STAA Ophthalmic Goods
  • XIFR
  • Sector
  • STAA Health Care
  • XIFR
  • Exchange
  • STAA Nasdaq
  • XIFR NYSE
  • Market Cap
  • STAA 850.9M
  • XIFR 815.0M
  • IPO Year
  • STAA N/A
  • XIFR N/A
  • Fundamental
  • Price
  • STAA $17.07
  • XIFR $8.46
  • Analyst Decision
  • STAA Hold
  • XIFR Sell
  • Analyst Count
  • STAA 8
  • XIFR 3
  • Target Price
  • STAA $27.17
  • XIFR $9.00
  • AVG Volume (30 Days)
  • STAA 817.0K
  • XIFR 931.6K
  • Earning Date
  • STAA 08-06-2025
  • XIFR 07-23-2025
  • Dividend Yield
  • STAA N/A
  • XIFR 21.47%
  • EPS Growth
  • STAA N/A
  • XIFR N/A
  • EPS
  • STAA N/A
  • XIFR N/A
  • Revenue
  • STAA $279,134,000.00
  • XIFR $1,255,000,000.00
  • Revenue This Year
  • STAA N/A
  • XIFR $11.14
  • Revenue Next Year
  • STAA $29.34
  • XIFR $2.34
  • P/E Ratio
  • STAA N/A
  • XIFR N/A
  • Revenue Growth
  • STAA N/A
  • XIFR 15.14
  • 52 Week Low
  • STAA $13.50
  • XIFR $7.53
  • 52 Week High
  • STAA $49.86
  • XIFR $29.03
  • Technical
  • Relative Strength Index (RSI)
  • STAA 43.92
  • XIFR N/A
  • Support Level
  • STAA $16.53
  • XIFR N/A
  • Resistance Level
  • STAA $17.31
  • XIFR N/A
  • Average True Range (ATR)
  • STAA 0.63
  • XIFR 0.00
  • MACD
  • STAA 0.01
  • XIFR 0.00
  • Stochastic Oscillator
  • STAA 22.30
  • XIFR 0.00

About STAA STAAR Surgical Company

Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.

About XIFR XPLR INFRASTRUCTURE LP

XPLR Infrastructure LP is formed to acquire, manage, and own contracted clean energy projects. It owns interests in wind and solar projects in North America, as well as natural gas infrastructure assets in Texas. Renewable energy assets consist of wind, solar, and solar-plus-storage projects and a stand-alone battery storage project, as well as contracted natural gas pipeline assets. Renewable energy sales generate maximum revenue for the company.

Share on Social Networks: